Yubo International Biotech Limited
YBGJOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$1006454
P/E Ratio—
52W High$0.1776
52W Low$0.0079
Yubo International Biotech Limited（YBGJ）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · YBGJ · 截至 2026-06-15
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($1.08M) | ($1.78M) | ($1.20M) | ($1.54M) | ($0.71M) |
| Depreciation & Amort. | $0.18M | $0.18M | $0.03M | $0.02M | $0.01M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | $0.17M | $0.25M | $1.25M | $0.49M | $0.80M |
| Net Cash from Operations | ($0.84M) | ($1.34M) | $0.07M | ($1.02M) | $0.10M |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | $0.00M | ($0.04M) | ($0.56M) | ($0.10M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.00M | $0.12M | ($0.04M) | ($0.56M) | ($0.10M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | — | — | — |
| Net Cash from Financing | $0.85M | $1.41M | $0.00M | $0.13M | $1.38M |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.84M) | ($1.34M) | $0.03M | ($1.59M) | $0.00M |
| FCF Margin %(computed) | -627.13% | — | 27.29% | -127.42% | 0.27% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · USD · M
深入了解Yubo International Biotech Limited
关于Yubo International Biotech Limited（YBGJ）现金流量表
Yubo International Biotech Limited 2025财年经营活动现金流($0.00B)，自由现金流($0.00B)（FCF利润率-627.13%），资本支出$0.00B。
常见问题
YBGJ · 4 问Yubo International Biotech Limited 2025财年自由现金流($0.00B)，同比up37.0%。
YBGJ free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15